Optimisation of a treat-to-target approach in rheumatoid arthritis: strategies for the 3-month time point

摘要

Background Treat-to-target (T2T) is a widely accepted management strategy for rheumatoid arthritis (RA) with a key decision point at 3 months after treatment initiation. At this time point, it remains unclear which patients will benefit from treatment adaptation or from continuation of existing treatment.